ARCHIVES

Beta Blockers Negate Harmful Recurrence Risks of ACE Inhibitors

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

USC Cancer Center Plans Expansion, Gets New Name

January 27, 1989

Efaproxyn Improved Survival Of Patients With Brain Mets

October 29, 2004

NCI Restructures AIDS Effort; New Research Thrusts Recommended

October 5, 1984

In Brief: FDA Approves Two Alpha Interferons; Canellos to Give Schwartz Lecture At Scripps Meeting

June 13, 1986

NCI To Broaden Support, Especially For Staff, Through Core Grants to Comprehensive Centers

November 21, 1975

Breast Cancer Low Fat Investigators to Seek R01 Funds for New Compliance, Biochemical Studies

April 25, 1986